Japan
Japan's insulin pen market sees 3% CAGR growth
The country comprised a 28% market share of insulin pens in the Asia-Pacific.
5 days ago
Japan's insulin pen market sees 3% CAGR growth
The country comprised a 28% market share of insulin pens in the Asia-Pacific.
5 days ago
Kurashiki Central Hospital names Akito Terai as new hospital and executive director
Sen Yamagata steps down from the role and assumes the role of general director.
Japan dental implants to reach $230m in 2033
Japan has accounted for over 12% of the dental implant market in APAC.
Private hospitals adopt more digital solutions vs public hospitals: report
Private hospitals prioritise digitisation for personalised patient information.
How hospitals in Japan procure medical resources: report
Public hospitals focus on quality care while private hospitals focus on efficiency.
Japan's medical devices exports to get hit by slow global growth
Its exports were valued at JPY1.t (US$8.2b) in 2022.
Japan sleep apnea equipment to grow US$100m in 2030: report
Long working hours, obesity and depression will propel the market's growth.
Diagnostic imaging to boost medical devices market in Japan
This is because of the growing integration of AI and data automation.
Japan's medical devices market to grow by 4.1% from 2022 to 2027
The orthopaedics and prosthetics market will be the fastest-growing.
Juntendo Clinic use robotic therapy for gait disorders
The robotic therapy can treat stroke and spinal cord injury.
Japan's HIV test market to reach US$58m in ten years
High-tech healthcare in Japan poses potential for improvement in HIV treatment and prevention.
Heart failure market to increase 5.2% CAGR by 2032
It is seen to increase to US$53b in 2032.
Ageing population, tech drive Japan’s medical device market
The country is already home to the highest senior population ratio in the world.
Japanese pharma company buys US drugmaker for $5.9b
The US firm is developing a treatment for one the major causes of vision loss in aging adults.
Japan’s Shin Nippon Biomedical Labs to buy US-based Satsuma for nasal powder migraine drug
Developed by Satsuma, STS101 is a nasal powder formulation of the anti-migraine drug, dihydroergotamine mesylate.
embecta Japan wins award for mobile app that supports diabetes patients between doctor visits
A free educational and lifestyle tool designed to help people with diabetes.
Japan’s over-the-counter drugs sector in the doldrums
An elevated demand for prescription drugs has held back demand for OTC drugs.
Most Read
1. Western Health takes home Healthcare Asia Awards 2024 for EMR system expansion 2. Global Doctors Hospital innovates holistic healthcare through wellness programmes 3. MSD navigates the pandemic tapestry in COVID-19 fight 4. ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education 5. Japan's insulin pen market sees 3% CAGR growthResource Center
Read Here
Advertise
Sign Up
Event News
Event News
MSD navigates the pandemic tapestry in COVID-19 fight
![MSD navigates the pandemic tapestry in COVID-19 fight]()
Co-Written / Partner
It has navigated the complexities of the challenging period through a proactive approach.
It has navigated the complexities of the challenging period through a proactive approach.
